Alterations in regional brain volume and individual MRI-guided perfusion in normal control, stable mild cognitive impairment, and MCI-AD converter

Journal of Geriatric Psychiatry and Neurology

Volumn 22, Issue 1, 2009, Pages 35-45

  Wang, Huali ^a,b   Golob, Edward ^c   Bert, Alberto ^a   Nie, Ke ^a   Chu, Yong ^d   Dick, Malcolm B ^a   Mandelkern, Mark ^a   Su, Min Ying ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^c Tulane University   (United States)

^d NONE

Author keywords

Medial temporal lobe; Memory function; Mild cognitive impairment; Perfusion; Volume

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; BRAIN SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; GRAY MATTER; HUMAN; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

AGED; AGING; ALZHEIMER DISEASE; BRAIN MAPPING; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; SEVERITY OF ILLNESS INDEX; TASK PERFORMANCE AND ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 63049128374     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988708328212     Document Type: Article

References (47)

1. Petersen RC Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. 2000 ; 15: 93-101.
2. Winblad B., Palmer K., Kivipelto M., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004 ; 256: 240-246.
3. Visser PJ, Scheltens P., Verhey FR, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 1999 ; 246: 477-485.
4. Krasuski JS, Alexander GE, Horwitz B., et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry. 1998 ; 43: 60-68.
5. Xu Y., Jack, CR Jr, O.'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000 ; 54: 1760-1767.
6. Jack CR, Petersen RC, Xu Y., et al. Medial temporal atrophy in MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997 ; 49: 786-794.
7. Selkoe DJ Alzheimer's disease is a synaptic failure. Science. 2002 ; 298: 789-791.
8. Guillozet AL, Weintraub S., Mash DC, Mesulam MM Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol. 2003 ; 60: 729-736.
9. Jack CR, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999 ; 52: 1397-1403.
10. Grundman M., Sencakova D., Jack CR, et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci. 2002 ; 19: 23-27.
11. Kantarci K., Jack CR Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am. 2003 ; 13: 197-209.
12. Grundman M., Lack CR, Petersen RC, et al. Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci. 2003 ; 20: 241-248.
13. El Fakhri G., Kijewski MF, Johnson KA, et al. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch Neurol. 2003 ; 60: 1066-1072.
14. Dubois B., Feldman HH, Jacova C., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007 ; 6: 734-746.
15. Kubota T., Ushijima Y., Yamada K., et al. Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy ? Eur J Nucl Med Mol Imaging. 2005 ; 32: 414-421.
16. Lee YC, Liu RS, Liao YC, et al. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. European Neurology. 2003 ; 49: 142-145.
17. Tanaka M., Fukuyama H., Yamauchi H., et al. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J Neuroimaging. 2002 ; 12: 112-118.
18. Kitayama N., Matsuda H., Ohnishi T., et al. Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease. Nucl Med Commun. 2001 ; 22: 473-477.
19. Huang C., Wahlund LO, Svensson L., et al. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol. 2002 ; 12: 2-9.
20. Kogure D., Matsuda H., Ohnishi T., et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000 ; 41: 1155-1162.
21. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 ; 56: 303-308.
22. Morris JC Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997 ; 9 (suppl 1). 173-176.
23. Wang H., Shu L., Xie J., et al. Diagnostic utility of neuropsychological performance and quantitative MRI-based measurement in Alzheimer's disease. Alzheimer Dis Assoc Disord. 2004 ; 18: 163-170.
24. Raz N., Dupuis JH, Briggs SD, et al. Differential effects of age and sex on the cerebellar hemispheres and the vermis: a prospective MR study. AJNR Am J Neuroradiol. 1998 ; 19: 65-71.
25. Lemieux L., Liu RSN, Duncan JS Hippocampal and cerebellar volumetry in serially acquired MRI volume scans. Magn Reson Imaging. 2000 ; 18: 1027-1033.
26. Lehericy S., Baulac M., Chiras J., et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol. 1994 ; 15: 929-937.
27. Ray K., Wang H., Chu Y., et al. Apparent diffusion coefficient in regional gray matter and white matter structures involved in mild cognitive impairment. Radiology. 2006 ; 241: 197-205.
28. Chang LT Method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978 ; 25: 638-643.
29. Pickut BA, Dierckx RA, Dobbeleir A., et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res. 1999 ; 90: 103-112.
30. Folstein MF, Folstein SE, McHugh PR 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12: 189-198.
31. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997 ; 9 (suppl 1). 65-69.
32. Morris JC, Heyman A., Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989 ; 39: 1159-1165.
33. Wechsler D. Wechsler Memory Scale-Revised. Mannual. San Antonio, TX: Harcourt Brace Jovanovich ; 1987.
34. Almkvist O. Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol Scand Suppl. 1996 ; 165: 63-71.
35. Price JL, Morris JC Tangles and plaques in nondemented aging and ''preclinical'' Alzheimer's disease. Ann Neurol. 1999 ; 45: 358-368.
36. Delacourte A., David JP, Sergeant N., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 1999 ; 52: 1158-1165.
37. Strange BA, Otten LJ, Josephs O., et al. Dissociable human perirhinal, hippocampal, and parahippocampal roles during verbal encoding. J Neurosci. 2002 ; 22: 523-528.
38. Huang C., Wahlund LO, Almkvist O., et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage. 2003 ; 19: 1137-1144.
39. Inoue K., Ito H., Goto R., et al. Apparent CBF decrease with normal aging due to partial volume effects: MRbased partial volume correction on CBF SPECT. Ann Nucl Med. 2005 ; 19: 283-290.
40. Barnden LR, Behin-Ain S., Kwiatek R., et al. Age related preservation and loss in optimized brain SPECT. Nucl Med Commun. 2005 ; 26: 497-503.
41. de Leon MJ, McRae T., Rusinek H., et al. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab. 1997 ; 82: 3251-3259.
42. De Santi S., de Leon MJ, Rusinek H., et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging. 2001 ; 22: 529-539.
43. de Leon MJ, Convit A., Wolf OT, et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A. 2001 ; 98: 10966-10971.
44. Nestor PJ, Fryer TD, Smielewski P., Hodges JR Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol. 2003 ; 54: 343-351.
45. Hickie IB, Naismith SL, Ward PB, et al. Psychomotor slowing in older patients with major depression: relationships with blood flow in the caudate nucleus and white matter lesions. Psychiatry Res. 2007 ; 155: 211-220.
46. Trollor JN, Sachdev PS, Haindl W., et al. Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography. Psychiatry Clin Neurosci. 2005 ; 59: 280-290.
47. Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol. 1995 ; 16: 637-643.